IP Library Granted Patent US 9,040,242
Granted Patent B2
US 9,040,242 · App. 13/553,256 · Granted May 26, 2015

Method to amplify nucleic acids to generate fluorescence labeled fragments of conserved and arbitrary products

Inventors: Anjana Agarwal (Wilmington, DE); Mark A. Jensen (West Chester, PA)
Assignee: E I DUPONT DE NEMOURS AND COMPANY
C12Q1/689C12Q1/686C12Q1/6846
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,040,242
App. No.
13/553,256
Granted
May 26, 2015
Kind
B2
Abstract

Disclosed herein are methods for the identification of the species, serotype, and strain of a microorganism. Also disclosed are primers for use in detecting such microorganisms and kits comprising such primers.

Claims (13)

1. A method for the identification of the species, serotype, and strain of a microorganism comprising:

(a) amplifying DNA comprising variable sequences interspersed between highly conserved rDNA sequences by PCR and amplifying additional genomic sequences by random amplified polymorphic DNA (RAPD) PCR using a first primer of 13-14 bases in length and a second primer of 11-13 bases in length, said first primer comprising:

(i) 11-12 contiguous bases from a highly conserved 16S rDNA region;

(ii) 2 bases at the 5′ end of said first primer that are not complementary to said highly conserved 16S rDNA region; and

(iii) a fluorescent label; and

(b) separating the amplified DNA produced in step (a).

2. The method of claim 1 , wherein said first primer is a forward primer.

3. The method of claim 2 , wherein said first primer comprises SEQ ID NO:1.

4. The method of claim 3 , wherein said first primer is SEQ ID NO:2.

5. The method of claim 1 , wherein said second primer comprises 11-13 contiguous bases from 23S rDNA.

6. The method of claim 5 , wherein said second primer is SEQ ID NO:3 or SEQ ID NO:4.

7. The method of claim 1 , wherein said amplifying step utilizes a third primer of 11-13 bases in length, said third primer comprising 11-13 contiguous bases from 23S rDNA, wherein said third primer is a different length than said second primer, and wherein one of either the second primer or third primer comprises 13 contiguous bases from 23S rDNA.

8. The method of claim 1 , wherein step (b) is accomplished by capillary electrophoresis.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Mar 18, 2021
From: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: QUALICON DIAGNOSTICS LLC
Reel/Frame 055644/0636 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS AT REEL/FRAME NO. 41983/0340 Recorded Mar 16, 2021
From: ANTARES CAPITAL LP, AS ADMINISTRATIVE AGENT
To: QUALICON DIAGNOSTICS LLC
Reel/Frame 055628/0366 →
SECURITY INTEREST Recorded Mar 16, 2017
From: QUALICON DIAGNOSTICS LLC, AS THE GRANTOR
To: ARES CAPITAL CORPORATION, AS SECOND LIEN ADMINISTRATIVE AGENT
Reel/Frame 041602/0334 →
FIRST LIEN PATENT SECURITY AGREEMENT Recorded Mar 13, 2017
From: QUALICON DIAGNOSTICS LLC
To: ANTARES CAPITAL LP, AS FIRST LIEN ADMINISTRATIVE AGENT
Reel/Frame 041983/0340 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2017
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: QUALICON DIAGNOSTICS LLC
Reel/Frame 041468/0214 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 31, 2012
From: AGARWAL, ANJANA; JENSEN, MARK A.
To: E. I. DU PONT DE NEMOURS AND COMPANY
Reel/Frame 028690/0912 →
Continuity (2)
Provisional Application 61511367 · Jul 25, 2011
Related Publication 20130029341A1 · Jan 31, 2013